Adakveo (crizanlizumab) is a monthly IV monoclonal antibody reducing frequency of sickle cell pain crises.

Amvuttra (vutrisiran) is a quarterly subcutaneous siRNA therapy that reduces TTR protein to treat ATTR–related nerve & heart disease.  

Avsola (infliximab-axxq) is a biosimilar to Remicade used to treat autoimmune conditions like RA, Crohn’s disease, and ulcerative colitis. 

Benlysta (belimumab) is a biologic for lupus and lupus nephritis to help control inflammation and disease flares.

Cinqair (reslizumab) is for severe eosinophilic asthma and targets IL-5 to reduce airway inflammation and asthma attacks.

Cinryze  is an intravenous C1 esterase inhibitor used to prevent hereditary angioedema attacks in patients aged 6 and older.

Cosentyx (secukinumab) is a biologic that blocks IL-17A to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and more.

Entyvio (vedolizumab) is a gut-selective biologic that treats moderate to severe ulcerative colitis and Crohn’s disease 

Evenity (romosozumab) is a biologic for osteoporosis in postmenopausal women that helps build bone and reduce fracture risk.

Fasenra (benralizumab) is used as an add-on maintenance treatment for severe eosinophilic asthma in patients aged 6 and older.

Feraheme (ferumoxytol) is an intravenous iron therapy for treating iron deficiency anemia, especially in chronic kidney disease.

Gammagard (immune globulin IV): provides passive immunity by supplying concentrated antibodies to treat immunodeficiency or autoimmune disorders.

Gamunex‑C (immune globulin): an IV/SC antibody therapy supplying immune support for immunodeficiency, neurologic & autoimmune conditions.

Givlaari (givosiran): a monthly subcutaneous RNAi therapy that lowers ALA levels to treat acute hepatic porphyria.

HyQvia (immune globulin + recombinant hyaluronidase): a monthly or biweekly SC infusion for immunodeficiency, offering longer intervals. 

Ilumya (tildrakizumab-asmn)is a biologic injection used to treat adults with moderate-to-severe plaque psoriasis.

Inflectra (infliximab-dyyb) is a biosimilar to Remicade used to treat autoimmune diseases like rheumatoid arthritis, Crohn’s disease, and psoriasis.

Injectafer (ferric carboxymaltose) is an intravenous iron therapy used to treat iron deficiency anemia.

Intravenous Immunoglobulin (IVIG) is an infusion of antibodies from donors, used to treat immune deficiencies and autoimmune diseases.

Keytruda (pembrolizumab): an immunotherapy that helps the immune system fight cancer by targeting the PD-1 pathway. 

Kisunla (donanemab): monthly IV antibody for early Alzheimer’s that targets amyloid plaques to slow cognitive decline.

Krystexxa (pegloticase) is an IV biologic that lowers uric acid to treat chronic gout not controlled by other medications.

Lemtrada (alemtuzumab) is an infusion therapy for relapsing MS, reducing relapses by targeting immune cells.

Leqembi (lecanemab): a biweekly IV antibody that clears amyloid plaques to slow early Alzheimer’s cognitive decline. 

MonoFerric (ferric derisomaltose): a single-dose IV iron infusion to rapidly replenish iron stores in iron deficiency anemia.

Nucala (mepolizumab) is a biologic injection that targets IL-5 to reduce eosinophils, treating severe asthma, EGPA, HES, and nasal polyps.

Nulojix (belatacept): a monthly IV biologic that helps prevent organ rejection in kidney transplant recipients by blocking T‑cell activation.

Ocrevus (ocrelizumab) is a twice-yearly infusion or injection for relapsing and primary progressive MS.

Octagam (immune globulin IV): provides antibodies to support immune-deficient patients and treat autoimmune disorders via monthly infusion. 

Onpattro (patisiran): a monthly IV siRNA therapy for hereditary ATTR amyloidosis that reduces TTR protein to slow neuropathy. 

Prolia (denosumab) is an injection to treat osteoporosis by slowing bone loss and increasing bone strength in postmenopausal women.

Privigen (immune globulin IV): monthly infusions of concentrated antibodies to treat immune deficiencies and certain autoimmune disorders. 

Qutenza (capsaicin 8% patch): a high-concentration topical treatment for temporary relief of peripheral neuropathic pain lasting up to 3 months.

Radicava (edaravone): a daily (5–6 day) IV infusion that slows functional decline in ALS by reducing oxidative stress.

Retacrit (epoetin alfa‑epbx): an IV/SC erythropoiesis‑stimulating agent treating anemia from CKD, chemotherapy, HIV AZT, or surgery. 

Reclast (zoledronic acid) is a once-yearly IV infusion used to treat or prevent osteoporosis by strengthening bones and reducing fracture risk.

Remicade (infliximab) is an IV biologic used to treat autoimmune diseases like rheumatoid arthritis, Crohn’s disease, and psoriasis.

Renflexis (infliximab-abda) is an IV biosimilar to Remicade, treating autoimmune diseases like RA, Crohn’s, UC, and psoriasis.

Rituxan (rituximab) is an IV biologic used to treat certain cancers and autoimmune diseases by targeting CD20-positive B cells.

Rystiggo (imidazoline tartrate): a daily oral medication that increases appetite and weight gain in adults with cachexia from chronic illness. 

Saphnelo (anifrolumab-fnia) is an IV biologic for adults with moderate to severe systemic lupus erythematosus.

Simponi Aria (golimumab) is an IV biologic for adults with RA, PsA, AS, and pJIA, reducing inflammation by blocking TNF-alpha. 

Skyrizi (risankizumab-rzaa) is for adults with moderate to severe plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.

Stelara (ustekinumab) is a biologic injection that treats plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. 

Soliris (eculizumab) is an IV biologic used to treat rare blood and neuromuscular diseases by inhibiting complement C5.

Spevigo (spesolimab-sbzo): a monthly IV antibody that rapidly resolves flares in generalized pustular psoriasis by targeting IL-36 receptor.

Tepezza (teprotumumab-trbw) is an IV therapy for Thyroid Eye Disease, reducing eye bulging and inflammation by targeting IGF-1R. 

Tezspire (tezepelumab-ekko) is a biologic injection for severe asthma, reducing airway inflammation by blocking TSLP.

Truxima (rituximab-abbs) is an IV biosimilar to Rituxan, treating NHL, CLL, RA, GPA, and MPA by targeting CD20-positive B cells. 

Tyenne (tocilizumab-aazg) is used to treat rheumatoid arthritis, giant cell arteritis, and juvenile idiopathic arthritis.

Tysabri (natalizumab) is an IV infusion for relapsing MS and Crohn’s disease, reducing inflammation.

Ultomiris (ravulizumab): a long‑acting IV complement inhibitor for paroxysmal nocturnal hemoglobinuria & atypical HUS, given every 8 weeks. 

Uplizna (inebilizumab-cdon): a biannual IV antibody that depletes B-cells to reduce relapses in neuromyelitis optica spectrum disorder.

Venofer (iron sucrose): an IV iron infusion for treating iron deficiency anemia, especially in chronic kidney disease or dialysis. 

Vyepti (eptinezumab-jjmr): a quarterly IV antibody that reduces frequency of migraine attacks by targeting CGRP.

Vyvgart (efgartigimod): a monthly IV antibody fragment reducing pathogenic IgG to improve muscle strength in generalized myasthenia gravis. 

Xolair (omalizumab): a SC antibody that blocks IgE to treat allergic asthma, chronic hives, and nasal polyps. 

Zinplava (bezlotoxumab): a single IV antibody dose that neutralizes C. difficile toxin B to prevent infection recurrence.

Zirabev (bevacizumab-bvzr): a biosimilar IV antibody that inhibits VEGF to treat various cancers like colorectal & lung.